LONDON, Jan. 14, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk ...
neffy 1 mg available nationwide for children aged four and older and co-promotion agreement with ALK-Abelló Inc. increases neffy promotional reach to nearly 20,000 healthcare providers, including key ...
San Diego’s ARS Pharmaceuticals, which is developing a non-injection nasal spray to combat severe allergic reactions, has inked a reverse merger that would boost its cash stockpile and make it a ...
Zacks Investment Research on MSN
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
Viatris VTRS announced the acquisition of Tokyo-based Aculys Pharma, a clinical-stage biopharmaceutical company specializing ...
If you don't use nasal spray correctly, it may not be as effective. Follow these steps to properly use your nasal spray.
(WJW) – If it works as billed, a nasal spray for migraines could be life-changing for millions of people who suffer from the debilitating health issue. The U.S. Food and Drug Administration approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback